All In Biotech

Drug Trial Radar · NCT05217927

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Last checked: Nov 19, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,415 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,415

Actual

Start

Mar 4, 2022

Primary completion

Oct 22, 2024

Study completion Dec 11, 2024

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Feb 1, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatment for episodic migraine.

Conditions

  • Migraine

Interventions

  • Rimegepant 75mg daily dosingDrug

    Daily

  • Rimegepant 75mg every other day dosingDrug

    Every other day

  • Placebo comparator dosingDrug

    Placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Observation Phase (OP) in the Number of Migraine Days Per Month Over Entire DBT Phase (Weeks 1 to 12)Time frame: Observation phase (from 31 days prior to randomization), DBT phase (through Month 3 [Week 1 to 12])

Locations

107 sites in 10 countries. Site status is shown where the registry gives one.

  • AMR Clinical

    Tempe, Arizona

  • Axiom Research, Llc

    Colton, California

  • Clinical Research Institute

    Los Angeles, California

  • Wr-Pri, Llc

    Newport Beach, California

  • California Neuroscience Research Medical Group, inc.

    Sherman Oaks, California

  • Neurology Offices of South Florida, PLLC

    Boca Raton, Florida

  • AppleMed Research Group, LLC

    Miami, Florida

  • Clinical Investigation Specialists, Inc.

    Gurnee, Illinois

  • MediSphere Medical Research Center, LLC

    Evansville, Indiana

  • Collective Medical Research

    Overland Park, Kansas

  • Clinvest Research, LLC

    Springfield, Missouri

  • Alliance for Multispecialty Research, LLC

    Las Vegas, Nevada

  • Dent Neurosciences Research Center, Inc.

    Amherst, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Upstate Clinical Research Associates, LLC

    Williamsville, New York

  • Wellnow Urgent Care and Research

    Columbus, Ohio

  • Hometown Urgent Care and Research

    Huber Heights, Ohio

  • Velocity Clinical Research, Medford

    Medford, Oregon

  • Preferred Primary Care Physicians, Inc.

    Pittsburgh, Pennsylvania

  • Velocity Clinical Research - Providence

    East Greenwich, Rhode Island

  • Velocity Clinical Research - Columbia

    Columbia, South Carolina

  • Velocity Clinical Research, Gaffney

    Gaffney, South Carolina

  • Tribe Clinical Research LLC

    Greenville, South Carolina

  • Clinical Research Associates, Inc.

    Nashville, Tennessee

  • FutureSearch Trials of Neurology

    Austin, Texas

  • FutureSearch Trials of Dallas, LP

    Dallas, Texas

  • Texas Center for Drug Development, Inc.

    Houston, Texas

  • APD Clinical Research

    Magnolia, Texas

  • Wasatch Clinical Research , LLC(Administrative Location)

    Salt Lake City, Utah

  • Seattle Clinical Research Center

    Seattle, Washington

  • Christian-Doppler-Klinik

    Salzburg, Austria

  • Medizinische Universitat Innsbruck

    Innsbruck, Tyrol, Austria

  • Calgary Headache & Assessment Management Program (CHAMP)

    Calgary, Alberta, Canada

  • OCT Research ULC

    Kelowna, British Columbia, Canada

  • James K. Lai MD Inc.

    Vancouver, British Columbia, Canada

  • Centricity Research

    Halifax, Nova Scotia, Canada

  • Aggarwal and Associates Limited

    Brampton, Ontario, Canada

  • Manna Research Inc. (Burlington North)

    Burlington, Ontario, Canada

  • Milestone Research Inc.

    London, Ontario, Canada

  • Bluewater Clinical Research Group Inc.

    Sarnia, Ontario, Canada

Showing 40 of 107 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.